IN2014MU00198A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00198A
IN2014MU00198A IN198MU2014A IN2014MU00198A IN 2014MU00198 A IN2014MU00198 A IN 2014MU00198A IN 198MU2014 A IN198MU2014 A IN 198MU2014A IN 2014MU00198 A IN2014MU00198 A IN 2014MU00198A
Authority
IN
India
Prior art keywords
modified release
release tablet
pregabalin
stomach
drug
Prior art date
Application number
Other languages
English (en)
Inventor
Sehgal Ashish
Setty Umesh
Patel Nilesh
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN198MU2014 priority Critical patent/IN2014MU00198A/en
Priority to PCT/IN2015/000032 priority patent/WO2015114655A2/en
Publication of IN2014MU00198A publication Critical patent/IN2014MU00198A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN198MU2014 2014-01-21 2015-01-20 IN2014MU00198A (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN198MU2014 IN2014MU00198A (ko) 2014-01-21 2015-01-20
PCT/IN2015/000032 WO2015114655A2 (en) 2014-01-21 2015-01-20 Modified release tablet of pregabalin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN198MU2014 IN2014MU00198A (ko) 2014-01-21 2015-01-20

Publications (1)

Publication Number Publication Date
IN2014MU00198A true IN2014MU00198A (ko) 2015-08-28

Family

ID=53757862

Family Applications (1)

Application Number Title Priority Date Filing Date
IN198MU2014 IN2014MU00198A (ko) 2014-01-21 2015-01-20

Country Status (2)

Country Link
IN (1) IN2014MU00198A (ko)
WO (1) WO2015114655A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106606495A (zh) * 2015-10-27 2017-05-03 四川海思科制药有限公司 一种普瑞巴林缓释片药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US8454993B2 (en) * 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
WO2012035559A2 (en) * 2010-09-17 2012-03-22 Panacea Biotec Ltd Sustained release pharmaceutical compositions comprising pregabalin

Also Published As

Publication number Publication date
WO2015114655A3 (en) 2016-01-28
WO2015114655A2 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
MX2017004876A (es) Proceso para preparar un eritritol directamente comprimible y usos de este.
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
HK1254389A1 (zh) 含有藥物的立即釋放片劑和用於形成片劑的方法
IL247986A0 (en) A therapeutic regimen containing an immediate release dose of an s1p modulator
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
IN2014DN06966A (ko)
NZ725577A (en) Modified release coated capsules
IL269464A (en) Needle-free cartridge for automatic drug compounder
HK1255969A1 (zh) 具有不依賴於ph釋放的軟膠囊
GEP20197020B (en) Vortioxetine pyroglutamate
NZ725578A (en) Modified release coated capsules
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
SG11201609948YA (en) Lobaplatin crystal, preparation method and pharmaceutical application
PH12016502272A1 (en) Ceritinib formulation
IN2014MU00198A (ko)
IN2014MU00215A (ko)
EP3189853A4 (en) Immune-induction-promoting composition including nuclear receptor ligand, and vaccine pharmaceutical composition
PT3129467T (pt) Ilhéus de porco transgénicos e seus usos para tratar a diabetes
PH12017500071A1 (en) Therapeutic agent for keratoconjunctive disorder
SI3236952T1 (sl) Farmacevtski sestavek v obliki tablet
HK1210723A1 (en) High dose extended-release potassium citrate wax matrix tablet
ZA201901004B (en) High drug loaded tablet composition for treating hiv
ZA201707549B (en) Extended release tablet comprising a weight-loss drug
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
IN2014MU00781A (ko)